Duane Morris Takeaway: This week’s episode of the Class Action Weekly Wire features Duane Morris partners Jerry Maatman and Jennifer Riley with their report on class action settlement trends at the halfway mark of 2025. Read our detailed breakdown of
Duane Morris Class Action Review – 2025/2026: Mid-Year Class Action Settlement Report & Analysis
By Gerald L. Maatman, Jr. and Jennifer A. Riley Duane Morris Takeaways: Corporate defendants saw unprecedented settlement numbers across all areas of class action litigation in 2022, 2023, and 2024, and halfway through 2025, settlement numbers remain robust. The cumulative value
How Will Trump v. CASA, Inc. Affect Class Certification Law?
The Supreme Court’s recent decision in Trump v. CASA, Inc., –– S. Ct. ––, 2025 WL 1773631 (U.S. June 27, 2025), restricting the use of “universal injunctions” by federal district courts, is receiving extensive attention regarding how it may
The Class Action Weekly Wire – Episode 107: Key State Court Rulings In Class Actions
Duane Morris Takeaway: This week’s episode of the Class Action Weekly Wire features Duane Morris partner Jennifer Riley and senior associate Ciara Dineen with their analysis of key developments in class action litigation in state courts, including significant rulings on
Chicago Skyway Toll Collector Dismissed From Illinois Consumer Fraud Class Action Lawsuit
By Gerald L. Maatman, Jr., George J. Schaller, and Jeremy H. Salinger Duane Morris Takeaways: On June 23, 2025, in Rowe, et al. v. Skyway Concession Company LLC, et al., No. 24-CV-6313, 2025 U.S. Dist. LEXIS 118449 (N.D. Ill. June
Current FDA Safety Investigation: NAION With Mounjaro, Zepbound, and Other GLP-1 RAs
Evaluating Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Possible Risk of NAION Side Effects
(Posted by Tom Lamb at Drug Injury Watch)
The FDA has been investigating “potential signals” of non-arteritic anterior ischemic optic neuropathy (NAION) with the
(Posted by Tom Lamb at Drug Injury Watch)
The FDA has been investigating “potential signals” of non-arteritic anterior ischemic optic neuropathy (NAION) with the
Sunglasses Manufacturer Cannot Settle Class Claims In Federal Court After Seven Years Of Litigation
By Gerald L. Maatman, Jr., Kevin E. Vance, and Ryan T. Garippo Duane Morris Takeaways: On June 17, 2025, in Smith, et al. v. Costa Del Mar, Inc., No. 18-CV-1011, 2025 WL 1697161 (M.D. Fla. June 17, 2025), Judge Timothy
Annual NYU Conference on Labor & Employment Law
By Shannon Noelle On June 9-10, NYU hosted its 77th annual conference on Labor & Employment Law, a non-partisan forum for stakeholders and experts to discuss current labor and employment policy and law. We were privileged to attend the conference
The Class Action Weekly Wire – Episode 106: Settlement Approval Issues In Class Actions
Duane Morris Takeaway: This week’s episode of the Class Action Weekly Wire features Duane Morris partner Jerry Maatman and senior associate Betty Luu with their analysis of settlement approval issues in class action litigation addressed by courts over the past
Transgender Worker Can Intervene In Bias Suit After EEOC Moves To Dismiss Action With Prejudice
By Gerald L. Maatman, Jr., Christian J. Palacios, and George J. Schaller Duane Morris Takeaways: On June 05, 2025, in EEOC et al., v. Sis-Bro, Inc., Case No. 3:24-CV-00968 (S.D. Ill. June 5, 2025), Judge J. Phil Gilbert of the